Democratizing Cancer Care

Precision oncology is revolutionizing cancer treatment for dogs, offering targeted therapies based on tumor DNA. With nearly six million canine cancer diagnoses annually and only 600 Veterinary oncologists in the U.S., most dogs lack access to specialists. However, precision medicine is becoming available to general veterinarians, allowing them to prescribe personalized, highly effective treatments that extend survival and maintain quality of life.

Previously limited to research centers, precision oncology is now accessible through genomic sequencing and AI-driven platforms. These treatments, often oral medications, are easier to administer and adjust compared to chemotherapy. Case studies, like Maggie and Pixelle, demonstrate the success of this approach, with tumors shrinking significantly after targeted therapies. By integrating genomic sequencing into Veterinary clinics, a vast database of canine cancer data is growing, accelerating new treatment discoveries. As precision oncology becomes standard, more pets will receive advanced, personalized cancer care, improving outcomes and transforming Veterinary oncology.